15-74897148-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2

The NM_002435.3(MPI):​c.982C>T​(p.Arg328Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0094 in 1,614,186 control chromosomes in the GnomAD database, including 101 homozygotes. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. R328R) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.0055 ( 4 hom., cov: 32)
Exomes 𝑓: 0.0098 ( 97 hom. )

Consequence

MPI
NM_002435.3 missense

Scores

1
5
12

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:10

Conservation

PhyloP100: 1.64

Publications

8 publications found
Variant links:
Genes affected
MPI (HGNC:7216): (mannose phosphate isomerase) Phosphomannose isomerase catalyzes the interconversion of fructose-6-phosphate and mannose-6-phosphate and plays a critical role in maintaining the supply of D-mannose derivatives, which are required for most glycosylation reactions. Mutations in the MPI gene were found in patients with carbohydrate-deficient glycoprotein syndrome, type Ib. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Jan 2014]
MPI Gene-Disease associations (from GenCC):
  • MPI-congenital disorder of glycosylation
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Orphanet, PanelApp Australia, Myriad Women’s Health, G2P, ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0074915886).
BP6
Variant 15-74897148-C-T is Benign according to our data. Variant chr15-74897148-C-T is described in ClinVar as Benign/Likely_benign. ClinVar VariationId is 94072.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.00555 (845/152310) while in subpopulation NFE AF = 0.0109 (739/68028). AF 95% confidence interval is 0.0102. There are 4 homozygotes in GnomAd4. There are 357 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check.
BS2
High Homozygotes in GnomAd4 at 4 AR gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
MPINM_002435.3 linkc.982C>T p.Arg328Trp missense_variant Exon 7 of 8 ENST00000352410.9 NP_002426.1 P34949-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
MPIENST00000352410.9 linkc.982C>T p.Arg328Trp missense_variant Exon 7 of 8 1 NM_002435.3 ENSP00000318318.6 P34949-1

Frequencies

GnomAD3 genomes
AF:
0.00556
AC:
846
AN:
152192
Hom.:
4
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.00147
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.00105
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.00
Gnomad FIN
AF:
0.00217
Gnomad MID
AF:
0.00316
Gnomad NFE
AF:
0.0109
Gnomad OTH
AF:
0.00287
GnomAD2 exomes
AF:
0.00554
AC:
1394
AN:
251486
AF XY:
0.00552
show subpopulations
Gnomad AFR exome
AF:
0.00154
Gnomad AMR exome
AF:
0.00101
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00291
Gnomad NFE exome
AF:
0.0108
Gnomad OTH exome
AF:
0.00586
GnomAD4 exome
AF:
0.00980
AC:
14330
AN:
1461876
Hom.:
97
Cov.:
31
AF XY:
0.00923
AC XY:
6712
AN XY:
727240
show subpopulations
African (AFR)
AF:
0.00182
AC:
61
AN:
33480
American (AMR)
AF:
0.00119
AC:
53
AN:
44724
Ashkenazi Jewish (ASJ)
AF:
0.000153
AC:
4
AN:
26136
East Asian (EAS)
AF:
0.00
AC:
0
AN:
39700
South Asian (SAS)
AF:
0.0000232
AC:
2
AN:
86256
European-Finnish (FIN)
AF:
0.00404
AC:
216
AN:
53420
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5768
European-Non Finnish (NFE)
AF:
0.0121
AC:
13492
AN:
1111996
Other (OTH)
AF:
0.00831
AC:
502
AN:
60396
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.467
Heterozygous variant carriers
0
831
1663
2494
3326
4157
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
518
1036
1554
2072
2590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.00555
AC:
845
AN:
152310
Hom.:
4
Cov.:
32
AF XY:
0.00479
AC XY:
357
AN XY:
74474
show subpopulations
African (AFR)
AF:
0.00147
AC:
61
AN:
41570
American (AMR)
AF:
0.000981
AC:
15
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3470
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5184
South Asian (SAS)
AF:
0.00
AC:
0
AN:
4830
European-Finnish (FIN)
AF:
0.00217
AC:
23
AN:
10616
Middle Eastern (MID)
AF:
0.00340
AC:
1
AN:
294
European-Non Finnish (NFE)
AF:
0.0109
AC:
739
AN:
68028
Other (OTH)
AF:
0.00284
AC:
6
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.500
Heterozygous variant carriers
0
45
91
136
182
227
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
20
40
60
80
100
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00893
Hom.:
20
Bravo
AF:
0.00527
TwinsUK
AF:
0.0113
AC:
42
ALSPAC
AF:
0.0156
AC:
60
ESP6500AA
AF:
0.00114
AC:
5
ESP6500EA
AF:
0.00908
AC:
78
ExAC
AF:
0.00610
AC:
741
Asia WGS
AF:
0.000866
AC:
3
AN:
3478
EpiCase
AF:
0.0102
EpiControl
AF:
0.00996

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:10
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:4
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Sep 01, 2024
CeGaT Center for Human Genetics Tuebingen
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

MPI: BS1, BS2 -

Jul 29, 2021
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 23806237) -

Nov 24, 2015
Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MPI-congenital disorder of glycosylation Benign:3
Nov 15, 2019
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

- -

Jan 13, 2018
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease. -

Jan 02, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2
Feb 12, 2021
Genetic Services Laboratory, University of Chicago
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Oct 16, 2012
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

MPI-related disorder Benign:1
Mar 19, 2020
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.097
BayesDel_addAF
Benign
-0.28
T
BayesDel_noAF
Benign
-0.16
CADD
Benign
18
DANN
Uncertain
0.99
DEOGEN2
Pathogenic
0.88
D;.;D;.
Eigen
Benign
-0.46
Eigen_PC
Benign
-0.42
FATHMM_MKL
Benign
0.41
N
LIST_S2
Benign
0.85
T;T;T;T
MetaRNN
Benign
0.0075
T;T;T;T
MetaSVM
Uncertain
0.46
D
MutationAssessor
Benign
1.8
L;.;.;.
PhyloP100
1.6
PrimateAI
Benign
0.21
T
PROVEAN
Benign
-2.1
N;N;N;N
REVEL
Uncertain
0.30
Sift
Uncertain
0.024
D;D;D;T
Sift4G
Uncertain
0.052
T;T;T;T
Polyphen
0.021
B;.;.;B
Vest4
0.19
MVP
0.87
MPC
0.21
ClinPred
0.013
T
GERP RS
3.1
Varity_R
0.10
gMVP
0.44
Mutation Taster
=99/1
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs117089191; hg19: chr15-75189489; COSMIC: COSV99052309; COSMIC: COSV99052309; API